Skip to main content Accessibility help
×
Home
  • Print publication year: 2012
  • Online publication date: May 2012

Chapter 10 - Amyotrophic lateral sclerosis and other disorders of the lower motor neuron

Summary

This chapter reviews the major advances in autosomal recessive and autosomal dominant ataxias, discusses the use of genetic tests in these disorders, and summarizes some current ideas regarding pathogenesis. It also presents a list of the autosomal recessive ataxias that have been genotypically characterized to date. Mutations in ataxia with isolated vitamin E deficiency (AVED) are scattered throughout the gene and some of them may be associated with a mild phenotype, late onset, retinitis pigmentosa, and retained reflexes. A syndrome of ataxia associated with optic atrophy, visual loss, and cochlear degeneration has been mapped to chromosome. The spinocerebellar ataxia (SCAs) exhibits many phenotypic similarities so that it is almost impossible to diagnose the genotype from the phenotype alone. Many persons from families with ataxia will request predictive testing and occasionally prenatal testing. Disease-modifying therapies are under investigation and include antioxidants and drugs that may modify excitotoxicity or apoptosis.

Related content

Powered by UNSILO

References

1. BrooksBR, MillerRG, SwashM, MunsatTL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–299.
2. DicksonDW, JosephsKA, Amador-OrtizC. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 2007; 114: 71–79.
3. KimWK, LiuX, SandnerJ, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009; 73: 1686–1692.
4. HodgesJR, MillarB. The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: Part I. Neurocase 2001; 7: 31–35.
5. AbrahamsS, GoldsteinLH, Al-ChalabiA, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1997; 62: 464–472.
6. KurlandLT, MulderDW. Age-specific incidence rates for motor neuron disease [letter]. J Neurol Neurosurg Psychiatry 1987; 50: 115–116.
7. MorrisHR, SteeleJC, CrookR, et al. Genome-wide analysis of the parkinsonism-dementia complex of Guam. Arch Neurol 2004; 61: 1889–1897.
8. KuzuharaS, KokuboY. Atypical parkinsonism of Japan: amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): an update. Mov Disord 2005; 20: S108–S113.
9. StrongMJ, HudsonAJ, AlvordWG. Familial amyotrophic lateral sclerosis, 1850–1989: a statistical analysis of the world literature. Can J Neurol Sci 1991; 18: 45–58.
10. SiddiqueT, FiglewiczDA, Pericak-VanceMA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity [published errata appear in N Engl J Med 1991; 325: 71 and 1991; 325: 524] [see comments]. N Engl J Med 1991; 324: 1381–1384.
11. RosenDR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 364: 362.
12. RosenDR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62.
13. ShawCE, EnayatZE, ChiozaBA, et al. Mutations in all five exons of SOD-1 may cause ALS. Ann Neurol 1998; 43: 390–394.
14. AndersenPM, NilssonP, Ala-HurulaV, et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet 1995; 10: 61–66.
15. PartonMJ, BroomW, AndersenPM, et al. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype. Hum Mutat 2002; 20: 473.
16. AndersenPM, NilssonP, KeranenML, et al. Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain 1997; 120: 1723–1737.
17. HaywardC, SwinglerRJ, SimpsonSA, BrockDJ. A specific superoxide dismutase mutation is on the same genetic background in sporadic and familial cases of amyotrophic lateral sclerosis [letter]. Am J Hum Genet 1996; 59: 1165–1167.
18. ClevelandDW, LiuJ. Oxidation versus aggregation – how do SOD1 mutants cause ALS?Nat Med 2000; 6: 1320–1321.
19. Bento-AbreuA, Van DammeP, Van Den BoschL, RobberechtW. The neurobiology of amyotrophic lateral sclerosis. Eur J Neurosci 2010; 31: 2247–2265.
20. Al-ChalabiA, HansenVK, SimpsonCL, et al. Variants in the ALS2 gene are not associated with sporadic amyotrophic lateral sclerosis. Neurogenetics 2003; 4: 221–222.
21. HadanoS, YanagisawaY, SkaugJ, et al. Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: candidate genes for ALS2. Genomics 2001; 71: 200–213.
22. YangY, HentatiA, DengHX, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet 2001; 29: 160–165.
23. TudorEL, PerkintonMS, SchmidtA, et al. ALS2/Alsin regulates Rac-PAK signaling and neurite outgrowth. J Biol Chem 2005; 280: 34735–34740.
24. HandCK, KhorisJ, SalachasF, et al. A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am J Hum Genet 2002; 70: 251–256.
25. ChancePF, RabinBA, RyanSG, et al. Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet 1998; 62: 633–640.
26. ChenYZ, BennettCL, HuynhHM, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004; 74: 1128–1135.
27. MoreiraMC, KlurS, WatanabeM, et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet 2004; 36: 225–227.
28. GrohmannK, SchuelkeM, DiersA, et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet 2001; 29: 75–77.
29. HentatiA, OuahchiK, Pericak-VanceMA, et al. Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics 1998; 2: 55–60.
30. AbalkhailH, MitchellJ, HabgoodJ, OrrellR, De BellerocheJ. A New familial amyotrophic lateral sclerosis locus on chromosome 16q12.1–16q12.2. Am J Hum Genet 2003; 73: 383–389.
31. RuddyDM, PartonMJ, Al-ChalabiA, et al. Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Hum Genet 2003; 73: 390–396.
32. SappPC, HoslerBA, McKenna-YasekD, et al. Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet 2003; 73: 397–403.
33. KwiatkowskiTJ Jr, BoscoDA, LeclercAL, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323: 1205–1208.
34. VanceC, RogeljB, HortobagyiT, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 1208–1211.
35. CrozatA, AmanP, MandahlN, RonD. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993; 363: 640–644.
36. LawWJ, CannKL, HicksGG. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic 2006; 5: 8–14.
37. YangS, WarraichST, NicholsonGA, BlairIP. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein. Int J Biochem Cell Biol 2010; 42: 1408–1411.
38. KovarH. Dr. Jekyll and Mr. Hyde: The two faces of the FUS/EWS/TAF15 protein family. Sarcoma 2011; 2011: 837474.
39. LingSC, AlbuquerqueCP, HanJS, et al. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci USA 2010; 107: 13318–13323.
40. BellyA, Moreau-GachelinF, SadoulR, GoldbergY. Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: exclusion from the nucleus and accumulation in dendritic granules and spine heads. Neurosci Lett 2005; 379: 152–157.
41. NishimuraAL, Mitne-NetoM, SilvaHC, et al. A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13. J Med Genet 2004; 41: 315–320.
42. NishimuraAL, Al-ChalabiA, ZatzM. A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum Genet 2005; 118: 499–500.
43. NishimuraAL, Mitne-NetoM, SilvaHC, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet 2004; 75: 822–831.
44. GreenwayMJ, AlexanderMD, EnnisS, et al. A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004; 63: 1936–1938.
45. Fernandez-SantiagoR, HoenigS, LichtnerP, et al. Identification of novel angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis. J Neurol 2009; 256: 1337–1342.
46. van EsMA, DiekstraFP, VeldinkJH, et al. A case of ALS-FTD in a large FALS pedigree with a K17I ANG mutation. Neurology 2009; 72: 287–288.
47. PaubelA, VioletteJ, AmyM, et al. Mutations of the ANG gene in French patients with sporadic amyotrophic lateral sclerosis. Arch Neurol 2008; 65: 1333–1336.
48. GelleraC, ColombritaC, TicozziN, et al. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics 2008; 9: 33–40.
49. CrabtreeB, ThiyagarajanN, PriorSH, et al. Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry 2007; 46: 11810–11818.
50. WuD, YuW, KishikawaH, et al. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 2007; 62: 609–617.
51. ConfortiFL, SprovieriT, MazzeiR, et al. A novel angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy. Neuromuscul Disord 2008; 18: 68–70.
52. CorradoL, BattistiniS, PencoS, et al. Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population. J Neurol Sci 2007; 258: 123–127.
53. GreenwayMJ, AndersenPM, RussC, et al. ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nat Genet 2006; 38: 411–413.
54. SeilheanD, CazeneuveC, ThuriesV, et al. Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathol 2009; 118: 561–573.
55. NeumannM, SampathuDM, KwongLK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130–133.
56. SreedharanJ, BlairIP, TripathiVB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008; 319: 1668–1672.
57. Lagier-TourenneC, ClevelandDW. Rethinking ALS: the FUS about TDP-43. Cell 2009; 136: 1001–1004.
58. ChowCY, LandersJE, BergrenSK, et al. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 2009; 84: 85–88.
59. PulsI, JonnakutyC, LaMonteBH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33: 455–456.
60. MunchC, SedlmeierR, MeyerT, et al. Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 2004; 63: 724–726.
61. MunchC, RosenbohmA, SperfeldAD, et al. Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann Neurol 2005; 58: 777–780.
62. MitchellJ, PaulP, ChenHJ, et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc Natl Acad Sci USA 2010; 107: 7556–7561.
63. MaruyamaH, MorinoH, ItoH, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010; 465: 223–226.
64. RezaieT, ChildA, HitchingsR, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002; 295: 1077–1079.
65. HoslerBA, SiddiqueT, SappPC, et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000; 284: 1664–1669.
65a. RentonAE, MajounieE, WaiteA, et al. A hexanucleotide repeat expansion in C90RF72 as the cause of chromosome 9p21 linked ALS-FTD. Neuron 2011; 72: 257–268.
65b. Dejesus-HernandezM, MackenzieIR, BoeveBF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C90RF72. Neuron 2011; 72: 245–256.
66. MoritaM, Al-ChalabiA, AndersenPM, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 2006; 66: 839–844.
67. VanceC, Al-ChalabiA, RuddyD, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2–21.3. Brain 2006; 129: 868–876.
68. Le BerI, CamuzatA, BergerE, et al. Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology 2009; 72: 1669–1676.
69. MomeniP, SchymickJ, JainS, et al. Analysis of IFT74 as a candidate gene for chromosome 9p-linked ALS-FTD. BMC Neurol 2006; 6: 44.
70. ValdmanisPN, DupreN, BouchardJP, et al. Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. Arch Neurol 2007; 64: 240–245.
71. JacksonM, Al-ChalabiA, EnayatZE, et al. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997; 42: 803–807.
72. JonesCT, SwinglerRJ, SimpsonSA, BrockDJ. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290–292.
73. NeumannM, RademakersR, RoeberS, et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009; 132: 2922–2931.